Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice
Kojouharov, Bojidar M, Brackett, Craig M, Veith, Jean M, Johnson, Christopher P, Gitlin, Ilya I, Toshkov, Ilia A, Gleiberman, Anatoli S, Gudkov, Andrei V, Burdelya, Lyudmila G
Published in Oncotarget (15.02.2014)
Published in Oncotarget (15.02.2014)
Get full text
Journal Article
The clinical-stage TLR5 agonist, Entolimod, mediates antimetastatic activity by stimulating a CXCR3-dependent NK-DC-CD8+ T cell axis
Brackett, Craig M, Kojouharov, Bojidar M., Gollnick, Sandra O., Burdelya, Lyudmila G., Abrams, Scott I, Gudkov, Andrei V.
Published in The Journal of immunology (1950) (01.05.2016)
Published in The Journal of immunology (1950) (01.05.2016)
Get full text
Journal Article